• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-PFO-025
Device Problem Biocompatibility (2886)
Patient Problems Embolus (1830); Thrombus (2101)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On (b)(6) 2018, a 25mm amplatzer pfo occluder was successfully implanted in a patient with a history of stroke.2 years post-procedure the patient presented with stroke.The echo revealed an obvious clot on the left disc, the presumptive site for the origin of the embolus.
 
Event Description
On (b)(6) 2018, a 25mm amplatzer pfo occluder was successfully implanted in a patient with a history of stroke, hypertension, diabetes, hyperlipidemia and tobacco user.2 years post-procedure the patient presented with stroke.The patient received a magnetic resonance imaging(mri) and computed tomography(ct) scan to confirm the stroke.The echo revealed an obvious clot on the left disc, the presumptive site for the origin of the embolus.The patient was placed on heparin drip and was given medication.The patient is currently discharged.
 
Manufacturer Narrative
Additional information for: b5, b7, g4, g7, h2, h6, and h10.An event of stroke two years after device implant was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis; however, one video was received for analysis.Based solely on the aforementioned video, a clot did appear to be attached to the disc of the device.Based on the information received, the cause of the reported incident could not be conclusively determined.Per the warnings section of the instructions for use, 600035-021 revision 1, stroke is a potential event due to device placement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10823080
MDR Text Key215975909
Report Number2135147-2020-00463
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PFO-025
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/13/2020
Initial Date FDA Received11/11/2020
Supplement Dates Manufacturer Received11/24/2020
Supplement Dates FDA Received12/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-